Specifically, both m6A deposition in splice site boundaries and in splicing and transcription factor transcripts, such as MYC, direct AS switches of specific BC-associated transcripts, which are associated with a poor overall survival rate in patients with BC, suggesting the use of these AS events as a novel potential prognostic biomarker [18]. The gene discussed is MYC; the disease is breast cancer.